case_images: PMC8635634_01
case_images: Changes in PSA levels and medications after diagnosis.
case_images: fonc-11-736975-g001.jpg
case_images: PMC8635634_01_fonc-11-736975-g001.jpg
case_images: f1
case_images: At the October 2020 admission, the patient's PSA level was elevated again due to disease progression ( Figure 1 ).
case_images: (A) Redness and swelling around the eyes; (B) Diffuse erythematous plaques involving perianal area; (C) Close-up view of the topical eruption.
case_images: fonc-11-736975-g002.jpg
case_images: PMC8635634_01_fonc-11-736975-g002.jpg
case_images: f2
case_images: Ten days after starting therapy, a physical examination found erythematous macules on his perineum, redness and swelling around the eyes, as well as facial edema ( Figure 2 ).
case_images: (A) Before treatment: diffuse erythema on the back; (B) After treatment: erythema basically disappeared.
case_images: fonc-11-736975-g003.jpg
case_images: PMC8635634_01_fonc-11-736975-g003.jpg
case_images: f3
case_images: Two days later, the lesions evolved to diffuse erythematous plaques all over the body ( Figure 3A ). After 12 days of stopping enzalutamide, systemic erythema significantly alleviated, and the skin surface appeared desquamated ( Figure 3B ).